Literature DB >> 10441838

The effects of NSAID on the matrix of human articular cartilages.

J T Dingle1.   

Abstract

The present paper presents data obtained over a 12 year period, on the matrix synthesis and turnover in some 650 arthritic and 180 non-arthritic (N) human cartilages using a standardised in vitro method. When the relative metabolic (synthetic/repair activity) of these human cartilages was compared, it was demonstrated that in osteoarthritis (OA) and rheumatoid arthritis (RA) cartilages synthetic activity was diminished by approximately 50% as compared with N cartilages. However, the turnover rate of matrix was not significantly different between Non-arthritic and OA, but was very substantially increased in RA cartilages compatible with the activity of inflammatory cells and proteolytic enzymes released from pannus. The action of 13 NSAIDs was compared in terms of their effect on cartilage GAG synthesis. 3 of these NSAIDs were also studied in terms of their effect on cartilage collagen synthesis. Consideration of the results in this study and from published material, led to the suggestion that NSAIDs may be divided into 3 categories in respect of their in vitro action on the extracellular matrix of human arthritic cartilages: 1. Those such as Aceclofenac, Tenidap and Tolmetin which can stimulate matrix synthesis 2. Those such as Piroxicam, Tiaprofenic Acid and Aspirin which appear to be without significant effect on matrix synthesis and, 3. Those like Naproxen, Ibuprofen, Indomethacin, Nimezulide which significantly inhibit matrix synthesis. It is suggested that the stimulatory action of group 1 NSAID is due to inhibition of locally produced IL1 and consequent expression of growth factor activity. Other NSAIDs may also inhibit IL1 synthesis or release, but probably do not have a beneficial effect on chondrocyte synthetic activity as they have toxic effects on cartilage metabolism. These experiments led to the suggestion that NSAIDs such as Aceclofenac would be appropriate for long-term treatment of arthritic conditions provided that one is prepared to extrapolate between in vitro experiments on human cartilage and what may be happening in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10441838     DOI: 10.1007/s003930050161

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  16 in total

1.  High density micromass cultures of a human chondrocyte cell line: a reliable assay system to reveal the modulatory functions of pharmacological agents.

Authors:  K V Greco; A J Iqbal; L Rattazzi; G Nalesso; N Moradi-Bidhendi; A R Moore; M B Goldring; F Dell'Accio; M Perretti
Journal:  Biochem Pharmacol       Date:  2011-09-16       Impact factor: 5.858

2.  Prostacyclin regulates bone growth via the Epac/Rap1 pathway.

Authors:  Michele R Hutchison; Perrin C White
Journal:  Endocrinology       Date:  2014-11-18       Impact factor: 4.736

3.  NSAID use in intervertebral disc degeneration: what are the effects on matrix homeostasis in vivo?

Authors:  Nicholas Vaudreuil; Tiffany Kadow; Takashi Yurube; Robert Hartman; Kevin Ngo; Qing Dong; Pedro Pohl; J Paulo Coelho; James Kang; Nam Vo; Gwendolyn Sowa
Journal:  Spine J       Date:  2017-04-14       Impact factor: 4.166

4.  "In vitro" differences among (R) and (S) enantiomers of profens in their activities related to articular pathophysiology.

Authors:  A M Panico; V Cardile; B Gentile; F Garufi; S Avondo; S Ronsisvalle
Journal:  Inflammation       Date:  2005-12       Impact factor: 4.092

5.  Naproxen induces type X collagen expression in human bone-marrow-derived mesenchymal stem cells through the upregulation of 5-lipoxygenase.

Authors:  Abdulrahman M Alaseem; Padma Madiraju; Sultan A Aldebeyan; Hussain Noorwali; John Antoniou; Fackson Mwale
Journal:  Tissue Eng Part A       Date:  2014-10-23       Impact factor: 3.845

Review 6.  A Roadmap of In Vitro Models in Osteoarthritis: A Focus on Their Biological Relevance in Regenerative Medicine.

Authors:  Isabella Bartolotti; Livia Roseti; Mauro Petretta; Brunella Grigolo; Giovanna Desando
Journal:  J Clin Med       Date:  2021-04-28       Impact factor: 4.241

7.  FlexPro MD, a Mixture of Krill Oil, Astaxanthin, and Hyaluronic Acid, Suppresses Lipopolysaccharide-Induced Inflammatory Cytokine Production Through Inhibition of NF-κB.

Authors:  Doo Ri Park; Ryeojin Ko; Suk Hyung Kwon; Bokkee Min; Seong Ho Yun; Manh Heun Kim; John Minatelli; Stephen Hill; Soo Young Lee
Journal:  J Med Food       Date:  2016-12       Impact factor: 2.786

8.  Effect of Topical Application of Nigella Sativa Oil and Oral Acetaminophen on Pain in Elderly with Knee Osteoarthritis: A Crossover Clinical Trial.

Authors:  Akram Kooshki; Reza Forouzan; Mohammad Hassan Rakhshani; Maryam Mohammadi
Journal:  Electron Physician       Date:  2016-11-25

9.  Engineering osteoarthritic cartilage model through differentiating senescent human mesenchymal stem cells for testing disease-modifying drugs.

Authors:  Ning Wang; Yuchen He; Silvia Liu; Meagan J Makarcyzk; Guanghua Lei; Alexander Chang; Peter G Alexander; Tingjun Hao; Anne-Marie Padget; Nuria de Pedro; Tsapekos Menelaos; Hang Lin
Journal:  Sci China Life Sci       Date:  2021-06-04       Impact factor: 6.038

10.  Cyclooxygenase inhibition lowers prostaglandin E2 release from articular cartilage and reduces apoptosis but not proteoglycan degradation following an impact load in vitro.

Authors:  Janet E Jeffrey; Richard M Aspden
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.